UW Vaccine & Treatment Evaluation Unit


December 28, 2020

Novavax COVID-19 Vaccine Trial

We are currently enrolling members of the public in a clinical trial of a Phase 3 vaccine for the prevention of COVID-19. Our research site is testing the SARS-CoV-2 recombinant spike protein nanoparticle vaccine that is now being developed as part of Operation Warp Speed by a new NIH network – the Coronavirus Prevention Network, or…